The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ho Carole since 2018.
This trader's CIK number is 1724605.
At the time of last reporting, Ho Carole was the Chief Medical Officer of Denali Therapeutics Inc.. (stock ticker symbol DNLI).
Also see all insider trading activities at Denali Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DNLI | 0 | $0 | 18,905 | $359,973 | 44,655 | $30,365 |
| 2024 | DNLI | 0 | $0 | 43,624 | $961,341 | 17,845 | $12,134 |
| 2023 | DNLI | 0 | $0 | 23,988 | $640,980 | 0 | $0 |
| 2022 | DNLI | 0 | $0 | 9,610 | $358,992 | 0 | $0 |
| 2021 | DNLI | 0 | $0 | 24,705 | $1,459,470 | 4,250 | $0 |
| 2020 | DNLI | 0 | $0 | 58,023 | $2,294,014 | 58,549 | $279,343 |
| 2019 | DNLI | 0 | $0 | 156,285 | $3,444,349 | 89,580 | $443,181 |
| 2018 | DNLI | 0 | $0 | 87,500 | $1,674,260 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-12 | DNLI | Sale | 2,937 | 13.58 | 39,884 |
| 2025-08-13 | DNLI | Sale | 806 | 14.64 | 11,799 |
| 2025-08-05 | DNLI | Option Ex | 44,655 | .68 | 30,365 |
| 2025-01-06 | DNLI | Sale | 12,255 | 20.22 | 247,796 |
| 2025-01-07 | DNLI | Sale | 2,907 | 20.81 | 60,494 |
| 2024-11-25 | DNLI | Option Ex | 17,845 | .68 | 12,134 |
| 2024-08-20 | DNLI | Sale | 2,453 | 23.79 | 58,356 |
| 2024-08-21 | DNLI | Sale | 20,005 | 24.68 | 493,823 |
| 2024-08-13 | DNLI | Sale | 2,337 | 22.89 | 53,493 |
| 2024-02-13 | DNLI | Sale | 2,784 | 17.29 | 48,135 |
| 2024-02-14 | DNLI | Sale | 1,405 | 17.79 | 24,994 |
| 2024-01-10 | DNLI | Sale | 4,668 | 19.02 | 88,785 |
| 2024-01-05 | DNLI | Sale | 9,972 | 19.43 | 193,755 |
| 2023-08-23 | DNLI | Sale | 2,522 | 23.22 | 58,560 |
| 2023-08-21 | DNLI | Sale | 2,478 | 22.60 | 56,002 |
| 2023-08-14 | DNLI | Sale | 2,768 | 23.79 | 65,850 |
| 2023-08-10 | DNLI | Sale | 2,857 | 24.15 | 68,996 |
| 2023-02-15 | DNLI | Sale | 1,476 | 29.40 | 43,394 |
| 2023-02-10 | DNLI | Sale | 818 | 29.80 | 24,376 |
| 2023-02-13 | DNLI | Sale | 2,548 | 30.10 | 76,694 |
| 2023-02-08 | DNLI | Sale | 1,521 | 30.88 | 46,968 |
| 2023-01-05 | DNLI | Sale | 2,636 | 28.44 | 74,967 |
| 2023-01-06 | DNLI | Sale | 1,451 | 28.67 | 41,600 |
| 2023-01-04 | DNLI | Sale | 2,913 | 28.69 | 83,573 |
| 2022-08-23 | DNLI | Sale | 2,424 | 31.98 | 77,519 |
| 2022-02-11 | DNLI | Sale | 2,918 | 34.71 | 101,283 |
| 2022-02-09 | DNLI | Sale | 1,423 | 37.10 | 52,791 |
| 2022-01-05 | DNLI | Sale | 2,845 | 44.78 | 127,399 |
| 2021-12-06 | DNLI | Sale | 1,476 | 42.52 | 62,759 |
| 2021-08-23 | DNLI | Sale | 6,143 | 48.91 | 300,454 |
| 2021-08-19 | DNLI | Sale | 2,546 | 49.61 | 126,307 |
| 2021-03-29 | DNLI | Sale | 2,822 | 54.62 | 154,126 |
| 2021-03-01 | DNLI | Sale | 7,092 | 67.94 | 481,802 |
| 2021-02-11 | DNLI | Sale | 3,156 | 70.83 | 223,526 |
| 2021-02-07 | DNLI | Option Ex | 4,250 | .00 | 0 |
| 2021-02-09 | DNLI | Sale | 1,470 | 75.17 | 110,496 |
| 2020-10-09 | DNLI | Sale | 30,000 | 41.09 | 1,232,850 |
| 2020-10-08 | DNLI | Sale | 22,906 | 40.12 | 918,988 |
| 2020-10-09 | DNLI | Option Ex | 30,000 | 5.28 | 158,400 |
| 2020-10-08 | DNLI | Option Ex | 22,906 | 5.28 | 120,943 |
| 2020-09-10 | DNLI | Sale | 3,689 | 31.00 | 114,359 |
| 2020-08-20 | DNLI | Option Ex | 5,643 | .00 | 0 |
| 2020-03-30 | DNLI | Sale | 1,428 | 19.48 | 27,817 |
| 2019-12-23 | DNLI | Sale | 3,464 | 20.01 | 69,314 |
| 2019-12-19 | DNLI | Sale | 2,566 | 20.00 | 51,320 |
| 2019-12-20 | DNLI | Sale | 860 | 20.00 | 17,200 |
| 2019-08-20 | DNLI | Option Ex | 5,643 | .00 | 0 |
| 2019-07-08 | DNLI | Option Ex | 6,511 | 5.28 | 34,378 |
| 2019-07-08 | DNLI | Sale | 17,500 | 20.39 | 356,877 |
| 2019-06-10 | DNLI | Sale | 17,500 | 18.74 | 327,897 |
| 2019-06-10 | DNLI | Option Ex | 4,617 | 5.28 | 24,377 |
| 2019-05-10 | DNLI | Sale | 5,862 | 22.16 | 129,931 |
| 2019-05-08 | DNLI | Sale | 5,775 | 23.50 | 135,741 |
| 2019-05-09 | DNLI | Sale | 5,863 | 23.22 | 136,127 |
| 2019-05-10 | DNLI | Option Ex | 2,546 | 5.28 | 13,442 |
| 2019-05-09 | DNLI | Option Ex | 2,653 | 5.28 | 14,007 |
| 2019-05-08 | DNLI | Option Ex | 2,613 | 5.28 | 13,796 |
| 2019-04-04 | DNLI | Sale | 9,588 | 26.62 | 255,232 |
| 2019-04-03 | DNLI | Sale | 15,450 | 26.54 | 410,043 |
| 2019-04-02 | DNLI | Sale | 15,580 | 24.98 | 389,235 |
| 2019-04-03 | DNLI | Option Ex | 5,862 | 5.28 | 30,951 |
| 2019-04-01 | DNLI | Sale | 5,775 | 23.91 | 138,080 |
| 2019-04-02 | DNLI | Option Ex | 6,135 | 5.28 | 32,392 |
| 2019-04-01 | DNLI | Option Ex | 5,775 | 5.28 | 30,492 |
| 2019-03-14 | DNLI | Option Ex | 500 | 5.28 | 2,640 |
| 2019-03-14 | DNLI | Sale | 1,000 | 25.01 | 25,010 |
| 2019-03-01 | DNLI | Option Ex | 5,775 | 5.28 | 30,492 |
| 2019-03-05 | DNLI | Sale | 5,862 | 21.96 | 128,729 |
| 2019-03-04 | DNLI | Sale | 5,863 | 22.36 | 131,067 |
| 2019-03-05 | DNLI | Option Ex | 5,862 | 5.28 | 30,951 |
| 2019-03-04 | DNLI | Option Ex | 5,863 | 5.28 | 30,956 |
| 2019-03-01 | DNLI | Sale | 5,775 | 22.55 | 130,197 |
| 2019-02-04 | DNLI | Option Ex | 3,869 | 5.28 | 20,428 |
| 2019-02-01 | DNLI | Sale | 5,775 | 18.64 | 107,646 |
| 2019-02-01 | DNLI | Option Ex | 5,775 | 5.28 | 30,492 |
| 2019-02-05 | DNLI | Sale | 7,856 | 18.83 | 147,928 |
| 2019-02-04 | DNLI | Sale | 3,869 | 18.80 | 72,737 |
| 2019-02-05 | DNLI | Option Ex | 7,856 | 5.28 | 41,479 |
| 2019-01-03 | DNLI | Sale | 2,777 | 18.90 | 52,485 |
| 2019-01-04 | DNLI | Option Ex | 5,950 | 5.28 | 31,416 |
| 2019-01-02 | DNLI | Sale | 5,775 | 19.84 | 114,547 |
| 2019-01-03 | DNLI | Option Ex | 5,775 | 5.28 | 30,492 |
| 2019-01-04 | DNLI | Sale | 5,950 | 19.66 | 117,006 |
| 2018-12-03 | DNLI | Sale | 17,500 | 18.80 | 328,930 |
| 2018-11-15 | DNLI | Sale | 17,500 | 18.07 | 316,155 |
| 2018-10-01 | DNLI | Sale | 17,500 | 21.72 | 380,100 |
| 2018-09-04 | DNLI | Sale | 17,500 | 19.05 | 333,375 |
| 2018-08-29 | DNLI | Sale | 17,500 | 18.04 | 315,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Carole (Chief Medical Officer of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.